Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localised Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00577356
What this trial is testing

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Benaroya Research Institute 6
Not applicableUnknownNCT04278261
What this trial is testing

Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer

Who this might be right for
Prostate CancerTreatment
Shanghai East Hospital 216
Testing effectiveness (Phase 2)WithdrawnNCT02159690
What this trial is testing

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

Who this might be right for
Prostate CancerLocalized Prostate Cancer
Kenneth Pienta, MD
Not applicableLooking for participantsNCT07042256
What this trial is testing

Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer

Who this might be right for
Localized Prostate Adenocarcinoma
University of Zurich 13
Not applicableUnknownNCT00573586
What this trial is testing

Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada

Who this might be right for
Prostate Cancer
SonaCare Medical 20
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Not applicableLooking for participantsNCT06052683
What this trial is testing

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 208
Not applicableEnded earlyNCT03290508
What this trial is testing

Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Myriad Genetic Laboratories, Inc. 524
Not applicableLooking for participantsNCT07560748
What this trial is testing

Prospective Prostate Cancer Infrastructure

Who this might be right for
High Risk Localized Prostate CancerSynchronous Metastatic Hormone-Sensitive Prostate Cancer
Radboud University Medical Center 700
Not applicableWithdrawnNCT03495479
What this trial is testing

Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance

Who this might be right for
Prostate Cancer
Omnitura Therapeutics, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT03769766
What this trial is testing

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 291
Not applicableUnknownNCT00770822
What this trial is testing

Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer

Who this might be right for
Prostate Cancer
SonaCare Medical 466
Testing effectiveness (Phase 2)Study completedNCT00138918
What this trial is testing

Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of British Columbia 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295447
What this trial is testing

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Universität Münster 190
Not applicableStudy completedNCT00188708
What this trial is testing

Effect of Casodex on Tumour Hypoxia - Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 30
Not applicableStudy completedNCT06273735
What this trial is testing

Prospective Trial: Acute Myocardial Injury After Radical Prostatectomy

Who this might be right for
Myocardial Injury
Martini-Klinik am UKE GmbH 1,000
Very early researchLooking for participantsNCT02526368
What this trial is testing

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Ivan de Kouchkovsky, MD 80
Testing effectiveness (Phase 2)Study completedNCT00828308
What this trial is testing

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Brown University 16
Not applicableLooking for participantsNCT02016248
What this trial is testing

SBRT Boost for Unfavorable Prostate Cancer'

Who this might be right for
Prostate Cancer
MemorialCare Health System 150
Not applicableLooking for participantsNCT07343349
What this trial is testing

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Who this might be right for
Prostate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate CarcinomaLocally Advanced Prostate Cancer+1 more
Rigshospitalet, Denmark 1,016
Next Page